Cargando…
Precision antimicrobial therapeutics: the path of least resistance?
The emergence of drug-resistant pathogens has led to a decline in the efficacy of traditional antimicrobial therapy. The rise in resistance has been driven by widespread use, and in some cases misuse, of antibacterial agents in treating a variety of infections. A growing body of research has begun t...
Autores principales: | Spaulding, Caitlin N., Klein, Roger D., Schreiber, Henry L., Janetka, James W., Hultgren, Scott J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829159/ https://www.ncbi.nlm.nih.gov/pubmed/29507749 http://dx.doi.org/10.1038/s41522-018-0048-3 |
Ejemplares similares
-
Narrowing the spectrum: the new frontier of precision antimicrobials
por: Paharik, Alexandra E., et al.
Publicado: (2017) -
The Path of Least Resistance
por: Jalli, Sandeep S., et al.
Publicado: (2021) -
Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist
por: Spaulding, Caitlin N., et al.
Publicado: (2017) -
Endocrine therapy: defining the path of least resistance
por: Stone, Andrew, et al.
Publicado: (2014) -
Precision oncology: Charting a path forward to broader deployment of genomic profiling
por: Schram, Alison M., et al.
Publicado: (2017)